Bioengineering lantibiotics for therapeutic success

Several examples of highly modified antimicrobial peptides have been described. While many such peptides are non-ribosomally synthesized, ribosomally synthesised equivalents are being discovered with increased frequency. Of the latter group, the lantibiotics continue to attract most attention. In th...

Full description

Bibliographic Details
Published in:	Frontiers in Microbiology
Main Authors:	Des eField, Paul David Cotter, Colin eHill, R Paul Ross
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-11-01
Subjects:	Bacteriocins Bioengineering Mutagenesis Nisin antimicrobial peptides lantibiotics
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01363/full

Similar Items

In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms
by: Des eField, et al.
Published: (2016-04-01)

Impact of bacteriocin-producing strains on bacterial community composition in a simplified human intestinal microbiota
by: Natalia S. Ríos Colombo, et al.
Published: (2023-12-01)

Nisin E Is a Novel Nisin Variant Produced by Multiple <i>Streptococcus equinus</i> Strains
by: Ivan Sugrue, et al.
Published: (2023-02-01)

In Silico Prediction and Analysis of Unusual Lantibiotic Resistance Operons in the Genus <i>Corynebacterium</i>
by: Oliver Goldbeck, et al.
Published: (2021-03-01)

Specificity and Application of the Lantibiotic Protease NisP
by: Manuel Montalbán-López, et al.
Published: (2018-02-01)

Bioengineered Nisin Derivative M17Q Has Enhanced Activity against <i>Staphylococcus epidermidis</i>
by: Ellen Twomey, et al.
Published: (2020-06-01)

A bioengineered nisin derivative, M21A, in combination with food grade additives eradicates biofilms of Listeria monocytogenes.
by: Lorraine Anne Draper, et al.
Published: (2016-11-01)

A Profile Hidden Markov Model to investigate the distribution and frequency of LanB-encoding lantibiotic modification genes in the human oral and gut microbiome
by: Calum J. Walsh, et al.
Published: (2017-04-01)

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
by: Johan A. Kers, et al.
Published: (2018-03-01)

Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens
by: Anna Desmond, et al.
Published: (2022-10-01)

The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity
by: Liang eZhou, et al.
Published: (2015-01-01)

Effect of the lantibiotic nisin on inhibitory and bactericidal activities of antibiotics used against vancomycin-resistant enterococci
by: Samah Sabry El-Kazzaz, et al.
Published: (2020-09-01)

Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review
by: Mateusz Musiejuk, et al.
Published: (2023-07-01)

Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin
by: Irina Panina, et al.
Published: (2021-09-01)

Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control
by: Natalia S. Ríos Colombo, et al.
Published: (2025-12-01)

Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy
by: Dayana N. Chernyshova, et al.
Published: (2022-11-01)

Kunkecin A, a New Nisin Variant Bacteriocin Produced by the Fructophilic Lactic Acid Bacterium, Apilactobacillus kunkeei FF30-6 Isolated From Honey Bees
by: Takeshi Zendo, et al.
Published: (2020-09-01)

Conjugation of Synthetic Polyproline Moietes to Lipid II Binding Fragments of Nisin Yields Active and Stable Antimicrobials
by: Jingjing Deng, et al.
Published: (2020-11-01)

The anti-adhesion effect of nisin as a robust lantibiotic on the colorectal cancer cells
by: Hesam Soleimanifar, et al.
Published: (2023-01-01)

Specific Synbiotic Sugars Stimulate <i>Streptococcus salivarius</i> BLIS K12 and BLIS M18 Lantibiotic Production to Expand Bacterial Inhibition Range and Potency
by: Liam K. Harold, et al.
Published: (2024-09-01)

Insights in the Antimicrobial Potential of the Natural Nisin Variant Nisin H
by: Jens Reiners, et al.
Published: (2020-10-01)

Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
by: Harsh Mathur, et al.
Published: (2017-06-01)

Editorial: Bacteriocins and other ribosomally synthesised and post-translationally modified peptides (RiPPs) as modulators of the microbiome
by: Harsh Mathur, et al.
Published: (2024-08-01)

A modified method for the turbidimetric assay of nisin
by: Simone Hickmann Flôres, et al.
Published: (2003-06-01)

Insights into the production and evolution of lantibiotics from a computational analysis of peptides associated with the lanthipeptide cyclase domain
by: Nikunj Maheshwari, et al.
Published: (2024-07-01)

Nisin: Prerequisites and Prospects for Application in the Medical Field
by: Oksana Knysh, et al.
Published: (2023-03-01)

The N-terminal Region of Nisin Is Important for the BceAB-Type ABC Transporter NsrFP from Streptococcus agalactiae COH1
by: Jens Reiners, et al.
Published: (2017-08-01)

Biotechnological applications of functional metagenomics in the food and pharmaceutical industries
by: Laura M Coughlan, et al.
Published: (2015-06-01)

Pseudocin 196, a novel lantibiotic produced by Bifidobacterium pseudocatenulatum elicits antimicrobial activity against clinically relevant pathogens
by: Rocio Sanchez-Gallardo, et al.
Published: (2024-12-01)

The prevalence and control of Bacillus and related spore-forming bacteria in the dairy industry
by: Nidhi eGopal, et al.
Published: (2015-12-01)

Heterologous Expression of Biopreservative Bacteriocins With a View to Low Cost Production
by: Beatriz Mesa-Pereira, et al.
Published: (2018-07-01)

Bactofencin A Displays a Delayed Killing Effect on a Clinical Strain of <i>Staphylococcus aureus</i> Which Is Greatly Accelerated in the Presence of Nisin
by: Paula M. O’Connor, et al.
Published: (2025-02-01)

Potential of Nisin and Newly Discovered Bacteriocins as Preservatives for Pasteurised Milk
by: Getrude Okiko, et al.
Published: (2024-12-01)

Insights into the Mode of Action of the Sactibiotic Thuricin CD
by: Colin Hill, et al.
Published: (2017-04-01)

Antibacterial effect of nisin in vitro
by: Marina M. Mishina, et al.
Published: (2020-12-01)

Anti-obesity effect of the bacterial product nisin in an NIH Swiss mouse model
by: M. K. Al-Emarah, et al.
Published: (2023-02-01)

Phylogeny-guided genome mining of roseocin family lantibiotics to generate improved variants of roseocin
by: Sandeep Chaudhary, et al.
Published: (2023-03-01)

Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus
by: Saswati Biswas
Published: (2023-02-01)

Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by Staphylococcus caledonicus
by: Michelle O’Connor, et al.
Published: (2024-08-01)

The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
by: Clare Piper, et al.
Published: (2012-01-01)